Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sabby Management (also referred to as Sabby Capital) is an active US-based hedge fund and investment firm specializing in activist investments, primarily in small cap healthcare, biotech, and therapeutics companies. It does not develop drugs itself but provides capital to companies in these sectors, often participating in rounds as a lead investor and maintaining a strong portfolio in the life sciences industry. Recently, it has acquired large positions in public companies such as Tonix Pharmaceuticals and frequently invests via warrants and structured equity vehicles. As an investment/hedge fund/venture firm, it is not a pipeline- or technology-based company and does not possess a clinical pipeline, platform technologies, nor direct drug programs; rather, it invests in and owns equity in companies that do.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sabby Investors.